• Focused on improving patient care

  • Quality matters

  • Understanding the fragility and value of life

  • Developing future solutions for unmet patient needs


News

21.11.2017
Octapharma donates 30.5 million international units of its medicine Nuwiq® to treat people with haemophilia in developing countries

Lachen, Switzerland, November 21st, 2017: Octapharma is pleased to announce the completion of a char...

02.11.2017
Octapharma USA Grant Supports Mission of First Hemophiliac to Climb the Seven Summits of the World

Hoboken, New Jersey, October 31st 2017: Octapharma USA has provided a grant to support the...

Since its establishment over 30 years ago, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map

“As a world-wide provider of human proteins as treatments in immunotherapy, haematology, and intensive care and emergency medicine, Octapharma is constantly investing in the renovation and modernisation of our plants.„

Wolfgang Marguerre
Chairman of the Board